Fulcrum Capital’s SPDR S&P Biotech ETF XBI Stock Holding History

Fulcrum Capital’s Portfolio XBI Stock Details XBI Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.56M	Buy	54,960 +3,122	+6%	+$259K	0.96%	35
2025 Q1	$4.2M	Buy	51,838 +2,172	+4%	+$176K	0.93%	33
2024 Q4	$4.47M	Buy	49,666 +1,470	+3%	+$132K	0.94%	34
2024 Q3	$4.76M	Buy	48,196 +669	+1%	+$66.1K	1.04%	33
2024 Q2	$4.41M	Buy	47,527 +1,800	+4%	+$167K	1%	33
2024 Q1	$4.34M	Sell	45,727 -371	-0.8%	-$35.2K	1.03%	33
2023 Q4	$4.12M	Buy	46,098 +313	+0.7%	+$27.9K	1.06%	33
2023 Q3	$3.34M	Buy	45,785 +483	+1%	+$35.3K	0.97%	33
2023 Q2	$3.77M	Sell	45,302 -2,064	-4%	-$172K	0.99%	34
2023 Q1	$3.61M	Sell	47,366 -513	-1%	-$39.1K	0.97%	34
2022 Q4	$3.97M	Buy	47,879 +1,996	+4%	+$166K	1.15%	34
2022 Q3	$3.64M	Sell	45,883 -1,443	-3%	-$114K	1.08%	40
2022 Q2	$3.52M	Sell	47,326 -26,041	-35%	-$1.93M	1.1%	34
2022 Q1	$6.59M	Buy	73,367 +7,965	+12%	+$716K	1.77%	26
2021 Q4	$7.32M	Buy	65,402 +5,801	+10%	+$649K	1.59%	26
2021 Q3	$7.49M	Buy	59,601 +3,409	+6%	+$429K	1.79%	26
2021 Q2	$7.61M	Buy	56,192 +2,822	+5%	+$382K	1.91%	24
2021 Q1	$7.24M	Sell	53,370 -3,175	-6%	-$431K	2.08%	19
2020 Q4	$7.96M	Buy	56,545 +602	+1%	+$84.7K	2.38%	13
2020 Q3	$6.23M	Sell	55,943 -4,910	-8%	-$547K	2.25%	20
2020 Q2	$6.81M	Sell	60,853 -5,440	-8%	-$609K	2.58%	11
2020 Q1	$5.13M	Sell	66,293 -746	-1%	-$57.8K	2.33%	25
2019 Q4	$6.38M	Buy	67,039 +1,162	+2%	+$111K	1.97%	26
2019 Q3	$5.02M	Buy	65,877 +1,002	+2%	+$76.4K	1.72%	29
2019 Q2	$5.69M	Sell	64,875 -7,496	-10%	-$657K	2.08%	24
2019 Q1	$6.55M	Buy	72,371 +2,889	+4%	+$262K	2.47%	13
2018 Q4	$4.99M	Buy	69,482 +2,865	+4%	+$206K	2.25%	19
2018 Q3	$6.39M	Sell	66,617 -4,329	-6%	-$415K	2.49%	13
2018 Q2	$6.75M	Sell	70,946 -3,696	-5%	-$352K	3.22%	11
2018 Q1	$6.55M	Buy	74,642 +23	+0%	+$2.02K	2.13%	13
2017 Q4	$6.33M	Buy	+74,619	New	+$6.33M	2.05%	15